New findings from the MATINEE and COPD-HELP studies suggest mepolizumab could reduce exacerbations and improve quality of life in patients with eosinophilic chronic obstructive pulmonary disease (COPD ...
A 12-week prospective cohort enrolled 73 patients with guideline-based asthma or COPD and no speech-affecting comorbidities, ...
Adding mepolizumab to inhaled triple therapy significantly improved exacerbation outcomes compared with placebo in adults with chronic obstructive pulmonary disease (COPD), based on data from the ...
A research team from the LKS Faculty of Medicine at the University of Hong Kong (HKUMed) has highlighted recent advances in understanding and managing COPD, particularly in relation to its ...
The evidence that glucose-lowering medications can improve symptoms of chronic obstructive pulmonary disease (COPD) in people with diabetes has been growing, but a few studies, including a clinical ...
Digital inhalers may help predict impending acute exacerbations of chronic obstructive pulmonary disease (COPD), according to a new study published in Chronic Obstructive Pulmonary Diseases: Journal ...
In one phase 3 trial, former smokers with COPD receiving itepekimab had a significantly lower annualized moderate/severe ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results